drugset / Trial / NCT02377713
A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of KHK6640, given as a single dose in Japanese patients with Mild to Moderate Alzheimer's Disease.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KHK6640 | Unknown | — | — |